FDA Peptide Reclassification 2026: What It Means for Providers RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Have patients been harmed by unsafe drug compounding? Partnership for Safe Medicines The Pharmacology of Longevity: Peptide Edition (Part 1)